Procter & Gamble Hygiene & Health Care Ltd. Stock Hits 52-Week Low at Rs.9941

3 hours ago
share
Share Via
Procter & Gamble Hygiene & Health Care Ltd. has reached a new 52-week low of Rs.9941, marking a significant decline in its stock price amid a challenging market environment and subdued performance metrics.
Procter & Gamble Hygiene & Health Care Ltd. Stock Hits 52-Week Low at Rs.9941

Stock Price Movement and Market Context

On 19 Mar 2026, the stock of Procter & Gamble Hygiene & Health Care Ltd. (Stock ID: 927063) touched Rs.9941, its lowest level in the past year. Despite outperforming its sector by 0.73% on the day, the stock traded within a narrow range of Rs.60, reflecting limited intraday price movement. However, the stock exhibited high volatility with an intraday weighted average volatility of 21.42%, indicating significant price fluctuations during trading hours.

The stock currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained downward trend. This technical positioning aligns with broader market conditions, where the Sensex opened sharply lower by 1,953.21 points but recovered partially to trade at 75,260.75, still down 1.88% for the day. Notably, the Sensex itself is trading below its 50-day moving average, which remains below the 200-day moving average, underscoring a bearish market phase.

Performance Relative to Benchmarks

Over the past year, Procter & Gamble Hygiene & Health Care Ltd. has underperformed significantly, delivering a negative return of 26.07%, compared to the Sensex’s marginal decline of 0.25%. The stock’s 52-week high was Rs.14,536.60, highlighting the extent of the recent price erosion. This underperformance extends beyond the last year, with the stock consistently lagging the BSE500 index across the previous three annual periods.

Financial and Valuation Metrics

The company’s long-term growth has been modest, with net sales increasing at an annualised rate of 5.52% and operating profit growing at 5.34% over the last five years. Despite this, the company maintains a high return on equity (ROE) of 92.3%, reflecting efficient capital utilisation. However, this strong ROE is accompanied by a high price-to-book value ratio of 34.9, indicating an expensive valuation relative to its book value.

Interestingly, the stock is currently trading at a discount compared to the average historical valuations of its peers, suggesting some valuation adjustment in the market. The company’s profits have risen by 20.1% over the past year, yet the price-earnings-to-growth (PEG) ratio stands at 1.9, which may be considered elevated given the growth rates.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Technical Indicators and Market Sentiment

Technical analysis of Procter & Gamble Hygiene & Health Care Ltd. reveals predominantly bearish signals. The Moving Average Convergence Divergence (MACD) indicator is bearish on both weekly and monthly charts. Bollinger Bands also indicate a bearish trend across these timeframes. The daily moving averages confirm this negative momentum, with the stock trading below all key averages.

Other technical tools such as the Know Sure Thing (KST) indicator and Dow Theory assessments show mild to strong bearishness on weekly and monthly scales. The On-Balance Volume (OBV) indicator similarly reflects mildly bearish sentiment, suggesting that selling pressure has been dominant in recent periods. Relative Strength Index (RSI) readings on weekly and monthly charts do not currently signal oversold or overbought conditions, indicating a neutral momentum stance.

Company Fundamentals and Shareholding

Procter & Gamble Hygiene & Health Care Ltd. maintains a strong balance sheet with an average debt-to-equity ratio of zero, reflecting a debt-free capital structure. The company’s management efficiency remains high, as evidenced by an ROE of 81.87% in recent assessments. Quarterly results for December 2025 showed record net sales of Rs.1,261.90 crore and a PBDIT of Rs.401.80 crore, with an operating profit margin of 31.84%, the highest recorded in recent quarters.

The majority shareholding remains with promoters, indicating stable ownership and control. Despite these positive fundamentals, the stock’s valuation and price performance have not aligned favourably in the current market environment.

Considering Procter & Gamble Hygiene & Health Care Ltd.? Wait! SwitchER has found potentially better options in FMCG and beyond. Compare this mid-cap with top-rated alternatives now!

  • - Better options discovered
  • - FMCG + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Sector and Index Performance

The FMCG sector, to which Procter & Gamble Hygiene & Health Care Ltd. belongs, also experienced pressure, with both the S&P BSE FMCG and NIFTY FMCG indices hitting new 52-week lows on the same day. This sector-wide weakness adds context to the stock’s decline, reflecting broader market dynamics rather than isolated company-specific issues.

The mid-cap classification of the company places it in a segment that has faced volatility and valuation adjustments in recent months, further influencing investor sentiment and price movements.

Summary of Rating and Market Position

MarketsMOJO assigns the stock a Mojo Score of 44.0 and a Mojo Grade of Sell, downgraded from Hold as of 17 Oct 2024. This rating reflects concerns over the company’s growth trajectory and valuation metrics relative to its peers. The mid-cap market capitalisation grade further contextualises the stock’s position within the broader market spectrum.

While the company demonstrates strong management efficiency and solid quarterly results, the stock’s price performance and technical indicators suggest continued caution in the current market environment.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News